Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 23,680 | 0 | 0 | 139,709 | 1,517 |
| Cost of Goods | 826 | N/A | N/A | N/A | N/A |
| Gross Profit | 22,854 | N/A | N/A | 139,709 | 1,517 |
| Operating Expenses | 363,352 | 229,954 | 151,757 | 113,489 | 72,940 |
| Operating Income | -339,672 | -229,954 | -151,757 | 26,220 | -71,423 |
| Interest Expense | 4,929 | 208 | 3,137 | 1,899 | 2,357 |
| Other Income | 25,843 | 20,802 | 5,556 | 605 | 622 |
| Pre-tax Income | -318,758 | -209,360 | -149,338 | 24,926 | -73,158 |
| Net Income Continuous | -318,758 | -209,360 | -149,338 | 24,926 | -73,158 |
| Net Income | $-318,758 | $-209,360 | $-149,338 | $24,926 | $-73,158 |
| EPS Basic Total Ops | -3.72 | -2.98 | -2.46 | 0.48 | -1.87 |
| EPS Basic Continuous Ops | -3.72 | -2.98 | -2.46 | 0.48 | -1.77 |
| EPS Diluted Total Ops | -3.72 | -2.98 | -2.46 | 0.46 | -1.87 |
| EPS Diluted Continuous Ops | -3.72 | -2.98 | -2.46 | 0.46 | -1.77 |
| EPS Diluted Before Non-Recurring Items | -3.72 | -2.98 | -2.46 | 0.48 | -1.87 |
| EBITDA(a) | $-353,102 | $-244,745 | $-155,106 | $26,907 | $-71,464 |